Market Overview:
The global autism spectrum disorder (ASD) treatment market is expected to register a CAGR of 10.8% during the forecast period, 2018-2030. The market growth can be attributed to factors such as increasing prevalence of ASD, growing awareness about ASD and its treatments, and rising government initiatives for the diagnosis and treatment of ASD. Based on type, the global autism spectrum disorder (ASD) treatment market is segmented into applied behavior analysis (ABA), discrete trial training (DTT), pivotal response training (PRT), and others. The ABA segment is expected to account for the largest share of the global autism spectrum disorder (ASD) treatment market in 2018. This can be attributed to the increasing demand for ABA therapies across all age groups with ASD symptoms.
 Treatment Industry Outlook.svg)
Product Definition:
ASD is a neurodevelopmental disorder that affects how people perceive and interact with the world around them. It can impair communication and social skills, as well as cause restricted or repetitive behaviors. There is no single cause of ASD, but it is believed to be caused by a combination of genetic and environmental factors. There is no cure for ASD, but treatment can help improve symptoms. Treatment may include therapies such as speech therapy, occupational therapy, or behavioral therapy; medications; or educational interventions.
Applied Behavior Analysis (ABA):
Applied behavior analysis is a method for analyzing the social communication and interaction of individuals with special needs. It's major application includes autism spectrum disorder (ASD) treatment, but it has many other applications as well. Applied behavior analysis is used to analyze the communicative and motor behaviors of individuals with developmental disabilities such as autism or Down syndrome.
Discrete Trial Training (DTT):
Autism spectrum disorder (ASD) is a group of neuro-developmental disorders, affecting social interaction, communication and behavior. ASD affects approximately 1 in every 10 children worldwide. The prevalence rate of this disorder increases with age; thus most affected individuals are diagnosed during their childhood or early adolescence.
The treatment for autism spectrum disorder includes various therapies and counseling which help the patient to develop social skills through systematic training.
Application Insights:
Autistic disorder held the largest share of over 30.0% in 2017. The rising prevalence of autistic disorders is one of the major factors driving this segment. According to a study published by CDC, in 2016, approximately 1 in 68 children are diagnosed with autism spectrum Disorder (ASD). In addition, according to another study published by NCBI in 2018, approximately 1 out of every 45 children have some symptoms or features that suggest they might have ASD during their first year of life. Thus, growing prevalence coupled with increasing awareness about early diagnosis is expected to drive this segment over the forecast period.
Asperger Syndrome held a significant share and is expected to grow at a lucrative rate during the forecast period due largely on its limited availability for diagnosis and treatment prior to 2014 when Applied Behavior Analysis (ABA) started being implemented on larger scales across countries such as United States.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to rising prevalence of autism spectrum disorders, increasing awareness about these disorders, and availability of highly skilled professionals in this region. Moreover, government initiatives for early diagnosis and treatment are also expected to propel the growth of this regional market over the forecast period. For instance, The National Institute of Neurological Disorders & Strokes (NINDS), a part of NIH is funding research activities on Fragile X Syndrome that includes Autism Spectrum Disorder (ASD). Such initiatives are anticipated to boost revenue generation in North America during the forecast period.
Asia Pacific is estimated to witness lucrative growth over the coming years owing to rise in disposable income coupled with growing healthcare expenditure by governments as well as individuals.
Growth Factors:
- Increasing awareness about ASD and its symptoms
- Growing number of research studies on ASD treatment and therapies
- Rising prevalence of autism spectrum disorder in children
- Availability of government funding for ASD research and treatment programs
- Growing demand for innovative and effective ASD treatments
Scope Of The Report
Report Attributes
Report Details
Report Title
Autism Spectrum Disorder (ASD) Treatment Market Research Report
By Type
Applied Behavior Analysis (ABA), Discrete Trial Training (DTT), Pivotal Response Training (PRT), Others
By Application
Autistic Disorder, Asperger Syndrome, Pervasive Developmental Disorder, Childhood Disintegrative Disorder
By Companies
Pfizer, SynapDx, Behavior Analysis, Autism Therapeutics, Curemark, Roche Pharmaceuticals, Fraser, Retrophin, AutismSTEP
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
227
Number of Tables & Figures
159
Customization Available
Yes, the report can be customized as per your need.
Global Autism Spectrum Disorder (ASD) Treatment Market Report Segments:
The global Autism Spectrum Disorder (ASD) Treatment market is segmented on the basis of:
Types
Applied Behavior Analysis (ABA), Discrete Trial Training (DTT), Pivotal Response Training (PRT), Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Autistic Disorder, Asperger Syndrome, Pervasive Developmental Disorder, Childhood Disintegrative Disorder
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- SynapDx
- Behavior Analysis
- Autism Therapeutics
- Curemark
- Roche Pharmaceuticals
- Fraser
- Retrophin
- AutismSTEP
 Treatment Market Overview.svg)
Highlights of The Autism Spectrum Disorder (ASD) Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Applied Behavior Analysis (ABA)
- Discrete Trial Training (DTT)
- Pivotal Response Training (PRT)
- Others
- By Application:
- Autistic Disorder
- Asperger Syndrome
- Pervasive Developmental Disorder
- Childhood Disintegrative Disorder
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Autism Spectrum Disorder (ASD) Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Treatment Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one-size-fits-all answer to this question, as the best ASD treatment will vary depending on the individual's specific needs. However, some common treatments for ASD include behavioral therapy, speech and language therapy, occupational therapy, and physical therapy.
Some of the major players in the autism spectrum disorder (asd) treatment market are Pfizer, SynapDx, Behavior Analysis, Autism Therapeutics, Curemark, Roche Pharmaceuticals, Fraser, Retrophin, AutismSTEP.
The autism spectrum disorder (asd) treatment market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Autism Spectrum Disorder (ASD) Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Autism Spectrum Disorder (ASD) Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Autism Spectrum Disorder (ASD) Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Autism Spectrum Disorder (ASD) Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Autism Spectrum Disorder (ASD) Treatment Market Size & Forecast, 2018-2028
4.5.1 Autism Spectrum Disorder (ASD) Treatment Market Size and Y-o-Y Growth
4.5.2 Autism Spectrum Disorder (ASD) Treatment Market Absolute $ Opportunity
Chapter 5 Global Autism Spectrum Disorder (ASD) Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Autism Spectrum Disorder (ASD) Treatment Market Size Forecast by Type
5.2.1 Applied Behavior Analysis (ABA)
5.2.2 Discrete Trial Training (DTT)
5.2.3 Pivotal Response Training (PRT)
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Autism Spectrum Disorder (ASD) Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Autism Spectrum Disorder (ASD) Treatment Market Size Forecast by Applications
6.2.1 Autistic Disorder
6.2.2 Asperger Syndrome
6.2.3 Pervasive Developmental Disorder
6.2.4 Childhood Disintegrative Disorder
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Autism Spectrum Disorder (ASD) Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Autism Spectrum Disorder (ASD) Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Autism Spectrum Disorder (ASD) Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Autism Spectrum Disorder (ASD) Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Autism Spectrum Disorder (ASD) Treatment Market Size Forecast by Type
9.6.1 Applied Behavior Analysis (ABA)
9.6.2 Discrete Trial Training (DTT)
9.6.3 Pivotal Response Training (PRT)
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Autism Spectrum Disorder (ASD) Treatment Market Size Forecast by Applications
9.10.1 Autistic Disorder
9.10.2 Asperger Syndrome
9.10.3 Pervasive Developmental Disorder
9.10.4 Childhood Disintegrative Disorder
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Autism Spectrum Disorder (ASD) Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Autism Spectrum Disorder (ASD) Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Autism Spectrum Disorder (ASD) Treatment Market Size Forecast by Type
10.6.1 Applied Behavior Analysis (ABA)
10.6.2 Discrete Trial Training (DTT)
10.6.3 Pivotal Response Training (PRT)
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Autism Spectrum Disorder (ASD) Treatment Market Size Forecast by Applications
10.10.1 Autistic Disorder
10.10.2 Asperger Syndrome
10.10.3 Pervasive Developmental Disorder
10.10.4 Childhood Disintegrative Disorder
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Autism Spectrum Disorder (ASD) Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Autism Spectrum Disorder (ASD) Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Autism Spectrum Disorder (ASD) Treatment Market Size Forecast by Type
11.6.1 Applied Behavior Analysis (ABA)
11.6.2 Discrete Trial Training (DTT)
11.6.3 Pivotal Response Training (PRT)
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Autism Spectrum Disorder (ASD) Treatment Market Size Forecast by Applications
11.10.1 Autistic Disorder
11.10.2 Asperger Syndrome
11.10.3 Pervasive Developmental Disorder
11.10.4 Childhood Disintegrative Disorder
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Autism Spectrum Disorder (ASD) Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Autism Spectrum Disorder (ASD) Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Autism Spectrum Disorder (ASD) Treatment Market Size Forecast by Type
12.6.1 Applied Behavior Analysis (ABA)
12.6.2 Discrete Trial Training (DTT)
12.6.3 Pivotal Response Training (PRT)
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Autism Spectrum Disorder (ASD) Treatment Market Size Forecast by Applications
12.10.1 Autistic Disorder
12.10.2 Asperger Syndrome
12.10.3 Pervasive Developmental Disorder
12.10.4 Childhood Disintegrative Disorder
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Autism Spectrum Disorder (ASD) Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Autism Spectrum Disorder (ASD) Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Autism Spectrum Disorder (ASD) Treatment Market Size Forecast by Type
13.6.1 Applied Behavior Analysis (ABA)
13.6.2 Discrete Trial Training (DTT)
13.6.3 Pivotal Response Training (PRT)
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Autism Spectrum Disorder (ASD) Treatment Market Size Forecast by Applications
13.10.1 Autistic Disorder
13.10.2 Asperger Syndrome
13.10.3 Pervasive Developmental Disorder
13.10.4 Childhood Disintegrative Disorder
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Autism Spectrum Disorder (ASD) Treatment Market: Competitive Dashboard
14.2 Global Autism Spectrum Disorder (ASD) Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 SynapDx
14.3.3 Behavior Analysis
14.3.4 Autism Therapeutics
14.3.5 Curemark
14.3.6 Roche Pharmaceuticals
14.3.7 Fraser
14.3.8 Retrophin
14.3.9 AutismSTEP
